From the Department of Joint Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Ann Saudi Med. 2024 May-Jun;44(3):195-211. doi: 10.5144/0256-4947.2024.195. Epub 2024 Jun 6.
The effect of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) therapy on knee osteoarthritis (KOA) has been contradictory in previous meta-analyses. This umbrella review on published meta-analyses aimed to investigate the effect of MSCs and PRP on KOA. We systematically searched Scopus, PubMed, and Cochrane databases to include related meta-analyses. The outcome included studies reporting visual analog scale scores, the Western Ontario and McMaster Universities Osteoarthritis Index, Whole-Organ Magnetic Resonance Imaging Scores, International Knee Documentation Committee scores, and the Knee injury and Osteoarthritis Outcome Score. A total of 28 meta-analyses with 32 763 participants. MSCs and PRP therapies were significantly associated with an improvement in KOA scores. This umbrella meta-analysis supports the beneficial health effects of MSCs and PRP in KOA.
先前的荟萃分析对间充质干细胞 (MSCs) 和富含血小板的血浆 (PRP) 疗法治疗膝骨关节炎 (KOA) 的效果存在争议。本项针对已发表荟萃分析的伞式综述旨在探究 MSCs 和 PRP 对 KOA 的疗效。我们系统地检索了 Scopus、PubMed 和 Cochrane 数据库,以纳入相关的荟萃分析。结局指标包括报告视觉模拟评分、西安大略和麦克马斯特大学骨关节炎指数、全器官磁共振成像评分、国际膝关节文献委员会评分和膝关节损伤和骨关节炎结果评分的研究。共纳入 28 项荟萃分析,包含 32763 名参与者。MSCs 和 PRP 疗法与 KOA 评分的改善显著相关。这项伞式 meta 分析支持 MSCs 和 PRP 对 KOA 有益的健康效果。